Evidence map›Paper›PMID 25282101›Full record

ArticleNature genetics2014

Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm.

Philippe Chetaille, Christoph Preuss, Silja Burkhard, Jean-Marc Côté, Christine Houde, Julie Castilloux, Jessica Piché, Natacha Gosset, Séverine Leclerc, Florian Wünnemann and 24 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Engineering precision zebrafish alleles of human disease.bioRxiv : the preprint server for biology · 2025
    Article
  5. Shugoshin 1 expression in various cancers: a potential target for therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Cellular and molecular basis of proximal small intestine disorders.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Article
  15. The zebrafish cohesin protein Sgo1 is required for cardiac function and eye development.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. BiallelicScience advances · 2022
    Article
  20. Somatic mosaicism inFrontiers in cell and developmental biology · 2022
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 12 institutions in 5 countries.

Philippe ChetailleDepartment of Pediatrics, Centre Mère Enfants Soleil, Centre Hospitalier de l'Université (CHU) de Québec, Quebec City, Quebec, Canada.
Christoph PreussCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Silja BurkhardHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands.
Jean-Marc CôtéDepartment of Pediatrics, Centre Mère Enfants Soleil, Centre Hospitalier de l'Université (CHU) de Québec, Quebec City, Quebec, Canada.
Christine HoudeDepartment of Pediatrics, Centre Mère Enfants Soleil, Centre Hospitalier de l'Université (CHU) de Québec, Quebec City, Quebec, Canada.
Julie CastillouxDepartment of Pediatrics, Centre Mère Enfants Soleil, Centre Hospitalier de l'Université (CHU) de Québec, Quebec City, Quebec, Canada.
Jessica PichéCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Natacha GossetCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Séverine LeclercCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Florian WünnemannCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Maryse ThibeaultCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Carmen GagnonCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Antonella GalliWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Elizabeth TuckWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Gilles R HicksonDepartment of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
Nour El AmineDepartment of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
Ines BoufaiedDepartment of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
Emmanuelle LemyreDepartment of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
Pascal de Santa BarbaraINSERM U1046, Montpellier, France.
Sandrine FaureINSERM U1046, Montpellier, France.
Anders JonzonDepartment of Women's and Children's Health, Section for Pediatrics, Astrid Lindgren's Children's Hospital, Uppsala University, Uppsala, Sweden.
Michel CameronCardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada.
Harry C DietzHoward Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Elena Gallo-McFarlaneHoward Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
D Woodrow BensonDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Claudia MoreauDepartment of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
Damian LabudaDepartment of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
FORGE Canada Consortium
Shing H ZhanMichael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
Yaoqing ShenMichael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
Michèle JompheProjet BALSAC, Université du Québec à Chicoutimi, Chicoutimi, Quebec, Canada.
Steven J M JonesMichael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
Jeroen BakkersHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000000294180422
Gregor Andelfinger1] Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada. [2] Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada. [3] Department of Biochemistry, Université de Montréal, Montreal, Quebec, Canada.
Centre Hospitalier Universitaire Sainte-Justine · CAUniversité de Montréal · CACentre hospitalier universitaire de Québec · CABC Cancer Agency · CAHoward Hughes Medical Institute · USInserm · FRRoyal Netherlands Academy of Arts and Sciences · NLWellcome Sanger Institute · GBBoston Children's Hospital · USCentre Hospitalier de l’Université de Montréal · CAMedical College of Wisconsin · USUniversité du Québec à Chicoutimi · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The pacemaking activity of specialized tissues in the heart and gut results in lifelong rhythmic contractions. Here we describe a new syndrome characterized by Chronic Atrial and Intestinal Dysrhythmia, termed CAID syndrome, in 16 French Canadians and 1 Swede. We show that a single shared homozygous founder mutation in SGOL1, a component of the cohesin complex, causes CAID syndrome. Cultured dermal fibroblasts from affected individuals showed accelerated cell cycle progression, a higher rate of senescence and enhanced activation of TGF-β signaling. Karyotypes showed the typical railroad appearance of a centromeric cohesion defect. Tissues derived from affected individuals displayed pathological changes in both the enteric nervous system and smooth muscle. Morpholino-induced knockdown of sgol1 in zebrafish recapitulated the abnormalities seen in humans with CAID syndrome. Our findings identify CAID syndrome as a novel generalized dysrhythmia, suggesting a new role for SGOL1 and the cohesin complex in mediating the integrity of human cardiac and gut rhythm.

Indexed as

Abnormalities, MultipleAnimalsArrhythmias, CardiacCell CycleCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsEnteric Nervous SystemFibroblastsFounder EffectGastrointestinal TractGene Knockdown TechniquesHumansIntestinal DiseasesKaryotypingMuscle ContractionCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsSGO1 protein, humanTransforming Growth Factor beta

Identifiers

PMID25282101
OpenAlexW2075458118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.